Table 1 Basic characteristics of the included studies

Cao Q et al. 2019

[40]

124

T:62

C:62

T:60.6 ± 2.9

C:60.1 ± 2.6

PMOP

Jintiange capsules + C

Alfacalcidol soft capsules

6 months

Y

a, c

Chen JR et al. 2019

[41]

160

T:80

C:80

T:65 ± 4

C:65 ± 4

PMOP

Jintiange capsules + C

Alendronate sodium tablets

8 months

N

a, b, c

Cheng JL et al. 2021

[42]

471

T:356 (46/310)

C:115 (14/101)

T:67.48 ± 9.11

C:66.65 ± 8.74

POP

Jintiange capsules + Gushukang capsules placebo

Jintiange capsules placebo + Gushukang capsules

6 months

Y

b

Deng XJ 2022

[43]

80

T:40 (21/19)

C:40 (23/17)

T:67.62 ± 2.87

C:67.52 ± 2.85

SOP

Jintiange capsules + C

Salmon calcitonin injection + Risedronate sodium tablets

3 months

N

a, c

Huang HL et al.2014

[44]

168

T:84

C:84

/

POP

Jintiange capsules + Diqiao vitamin D calcium chewable tablets

Alendronate sodium tablets + Diqiao vitamin D calcium chewable tablets

3 months

Y

b

Ji QX et al. 2021

[45]

120

T:60 (36/24)

C:60 (33/27)

T:65.40 ± 2.55

C:65.48 ± 2.66

POP

Jintiange capsules + C

Caltrate D3 + Sodium Ibandronate Injection

6 months

Y

b, c, d, f

Kong HY et al. 2022

[46]

60

T:30

C:30

T:59.40 ± 2.95

C:58.90 ± 2.30

PMOP

Jintiange capsules + C

Alendronate sodium tablets + Caltrate D3

6 months

Y

c

Liang HT et al. 2022

[31]

399

T:199 (24/175)

C:200 (29/171)

T:63.31 ± 7.02

C:62.88 ± 7.42

POP

Jintiange capsules + Caltrate D3 placebo + Alfacalcidol soft capsules

Caltrate D3 + Jintiange capsules placebo + Alfacalcidol soft capsules

13 months

N

a, c, e, f

Liu MY 2016

[47]

116

T:58 (22/36)

C:58 (24/34)

T:71 ± 5

C:70 ± 6

SOP

Jintiange capsules + C

Alendronate sodium tablets + Caltrate D3

12 months

N

a, b, c, d

Liu ZY 2018

[48]

151

T:76

C:75

T:59.96 ± 9.24

C:59.48 ± 9.35

PMOP

Jintiange capsules + C

Risedronate sodium capsules

6 months

Y

c

Luo Q et al. 2016

[49]

112

T:56

C:56

/

SOP

Jintiange capsules + Alendronate sodium tablets

Alendronate sodium tablets + Caltrate D3

6 months

Y

a, c, f

Qi YJ et al. 2017

[50]

133

T:87

C:46

T:65.30 ± 10.90

C:63.90 ± 14.80

PMOP

Jintiange capsules + C

Alendronate sodium tablets + Caltrate D3

6 months

Y

a, b, c

Tian F et al. 2019

[51]

120

T:60 (27/33)

C:60 (26/34)

T:62.83 ± 5.65

C:62.95 ± 5.71

POP

Jintiange capsules + C

Calcitriol soft capsules

6 months

Y

a, b, c

Wang RR 2018

[52]

68

T:34

C:34

T:63.01 ± 10.82

C:64.12 ± 10.86

PMOP

Jintiange capsules + C

Zoledronic acid injection

6 months

N

a, b, c

Wei LY et al. 2018

[53]

76

T:38

C:38

/

POP

Jintiange capsules

Caltrate D3 + Vitamin D

6 months

N

b, d

Xu RM et al. 2017

[54]

100

T:50

C:50

T:61.47 ± 17.38

C:61.98 ± 6.92

PMOP

Jintiange capsules + C

Estradiol valerate tablets

12 months

N

a

Xu YF et al. 2018

[55]

60

T:30

C:30

T:65.32 ± 3.31

C:65.99 ± 3.02

PMOP

Jintiange capsules + C

Caltrate D3

1 months

N

b

Xue L et al. 2023

[56]

98

T:49 (24/25)

C:49 (21/28)

T:62.17 ± 7.72

C:61.86 ± 7.65

POP

Jintiange capsules + C

Calcitriol soft capsules + Caltrate D3

6 months

Y

b

Yuan YF et al. 2019

[57]

160

T:80

C:80

T:67 ± 7

C:69 ± 7

PMOP

Jintiange capsules

Caltrate D3

3 months

N

c, e

Zhang XC et al. 2019

[58]

46

T:23

C:23

/

SOP

Jintiange capsules + C

Salmon calcitonin injection

3 months

N

b, c

Zhang Y et al. 2019

[59]

94

T:47

C:47

T:59.60 ± 7.40

C:59.40 ± 7.10

PMOP

Jintiange capsules + C

Risedronate sodium capsules

6 months

Y

a, c